Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-019744 General Corporate
Debt relative to revenue 100th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
405.29% · OPTIONAL · VALID
Capex intensity 8th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.04% · OPTIONAL · VALID
Operating cash generation 46th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.58% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
-20.73% · CORE · VALID
Gross margin 8th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
63.43% · CORE · VALID
Operating margin 8th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
-30.14% · CORE · VALID
R&D intensity 100th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
41.66% · OPTIONAL · VALID
SBC intensity 92th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
18.06% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 334.51%
Current 405.29%
Delta 70.77% Capex Intensity Increased
Previous 0.82%
Current 2.04%
Delta 1.22% Cash Generation Increased
Previous -2.53%
Current 9.58%
Delta 12.12% Growth Decreased
Previous -11.40%
Current -20.73%
Delta -9.33% Margin Decreased
Previous 68.70%
Current 63.43%
Delta -5.28% Profitability Decreased
Previous -2.36%
Current -30.14%
Delta -27.78% R And D Intensity Increased
Previous 35.26%
Current 41.66%
Delta 6.41% Sbc Intensity Increased
Previous 14.91%
Current 18.06%
Delta 3.16% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.